These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

212 related items for PubMed ID: 11437589

  • 1. The use of interferon beta at the time of initial diagnosis of multiple sclerosis.
    Pender MP.
    J Clin Neurosci; 2001 Jul; 8(4):381-2. PubMed ID: 11437589
    [No Abstract] [Full Text] [Related]

  • 2. Should all patients with an initial diagnosis of multiple sclerosis be treated with beta interferon?
    Hodgkinson SJ.
    J Clin Neurosci; 2001 Jul; 8(4):378-9. PubMed ID: 11437587
    [No Abstract] [Full Text] [Related]

  • 3. Should all patients with an initial diagnosis of multiple sclerosis be treated with beta interferon? The case against.
    Macdonell R.
    J Clin Neurosci; 2001 Jul; 8(4):379-81. PubMed ID: 11437588
    [No Abstract] [Full Text] [Related]

  • 4. The treatment of multiple sclerosis with beta-interferon.
    Poser CM.
    Neuroepidemiology; 2008 Jul; 31(3):157-8. PubMed ID: 18716413
    [No Abstract] [Full Text] [Related]

  • 5. [Diagnostics and drug therapy of multiple sclerosis].
    Suomen Neurologinen Yhdistys ry.
    Duodecim; 2002 Jul; 118(13):1411-23. PubMed ID: 12239889
    [No Abstract] [Full Text] [Related]

  • 6. Interferon beta for treatment of multiple sclerosis.
    Wilson BA.
    Medsurg Nurs; 1995 Apr; 4(2):151-3. PubMed ID: 7711824
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Interferon-beta treatment in patients with childhood-onset multiple sclerosis.
    Mikaeloff Y, Moreau T, Debouverie M, Pelletier J, Lebrun C, Gout O, Pedespan JM, Van Hulle C, Vermersch P, Ponsot G.
    J Pediatr; 2001 Sep; 139(3):443-6. PubMed ID: 11562627
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Should neutralizing antibodies be monitored during interferon-beta treatment for multiple sclerosis?
    Oger J, Gibbs E.
    Nat Clin Pract Neurol; 2006 Feb; 2(2):76-7. PubMed ID: 16932528
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Patient and family fact sheet. Current treatments for multiple sclerosis.
    Kernich CA.
    Neurologist; 2005 Mar; 11(2):137-8. PubMed ID: 15733335
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.